tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Rocket Pharmaceuticals Inc

RCKT
Add to Watchlist
3.110USD
-0.100-3.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
339.59MMarket Cap
LossP/E TTM

Rocket Pharmaceuticals Inc

3.110
-0.100-3.12%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

RCKT Financials

See Rocket Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rocket Pharmaceuticals Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.42/-0.41
Revenue / Forecast
0.00/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.01
26.43%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
23.81%-0.42
38.47%-0.38
36.33%-0.45
16.44%-0.62
16.01%-0.56
3.14%-0.62
5.40%-0.71
9.00%-0.74
9.65%-0.66
26.91%-0.64
---0.75
---0.82
---0.73
---0.87
---2.37
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
22.40%-47.59M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
10.59%-59.66M
-7.17%-61.90M
-20.77%-65.70M
-35.72%-58.34M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.40M
-6.98%-42.98M
27.36%-44.25M
-72.35%-50.12M
-37.88%-34.52M
Debt to assets ratio
65.22%7.45%
59.96%6.44%
7.21%5.78%
6.36%5.05%
6.42%4.51%
7.80%4.02%
52.88%5.39%
4.04%4.75%
3.70%4.24%
-1.92%3.73%
--3.53%
--4.56%
--4.09%
--3.81%
--5.02%
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
24.66%-48.51M
29.77%-44.03M
24.49%-52.42M
8.19%-67.68M
4.43%-64.39M
-2.14%-62.69M
-8.26%-69.42M
-7.21%-73.71M
-8.33%-67.38M
8.64%-61.38M
-12.14%-64.13M
-26.83%-68.76M
-46.12%-62.19M
-51.54%-67.18M
-15.19%-57.19M
-59.22%-54.21M
-8.52%-42.56M
25.16%-44.33M
-81.28%-49.65M
-44.52%-34.05M
Net Profit
22.40%-47.59M
29.49%-42.54M
24.56%-50.33M
1.04%-68.92M
1.16%-61.33M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
10.59%-59.66M
-7.17%-61.90M
-20.77%-65.70M
-35.72%-58.34M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.40M
-6.98%-42.98M
27.36%-44.25M
-72.35%-50.12M
-37.88%-34.52M
Balance Sheet
Current assets
-53.83%149.83M
-49.04%192.73M
-5.82%227.68M
-5.32%277.15M
-5.99%324.49M
-0.01%378.18M
-45.90%241.75M
-6.20%292.73M
2.11%345.16M
3.89%378.22M
43.63%446.87M
-4.20%312.07M
-4.47%338.03M
-7.14%364.06M
-26.80%311.13M
-24.31%325.77M
-25.00%353.85M
-19.55%392.06M
82.27%425.07M
68.51%430.43M
Total current liabilities
-30.71%24.47M
-25.75%30.21M
-22.04%31.17M
15.45%43.40M
7.14%35.31M
-16.12%40.68M
19.43%39.98M
9.45%37.59M
5.61%32.96M
23.84%48.51M
10.92%33.48M
41.41%34.35M
38.26%31.21M
76.70%39.17M
23.24%30.18M
-4.54%24.29M
-44.26%22.57M
-32.04%22.17M
-23.36%24.49M
23.01%25.44M
Total assets
-39.41%285.41M
-37.38%330.45M
-6.52%368.03M
-5.70%420.98M
-5.68%471.07M
-6.82%527.70M
-34.25%393.69M
-3.33%446.41M
-2.98%499.44M
2.63%566.34M
43.50%598.76M
6.93%461.78M
11.87%514.76M
11.02%551.81M
-21.31%417.26M
-19.30%431.85M
-20.18%460.15M
-15.88%497.02M
58.05%530.24M
51.57%535.15M
Total liabilities
-19.62%47.37M
-17.43%53.23M
-14.95%54.36M
8.08%66.77M
1.71%58.93M
-12.61%64.47M
10.82%63.92M
5.04%61.78M
3.68%57.94M
18.75%73.77M
15.46%57.68M
33.19%58.81M
31.39%55.88M
46.87%62.12M
12.04%49.95M
-3.41%44.16M
-55.92%42.53M
-51.55%42.30M
-52.40%44.58M
-47.17%45.72M
Total equity
-42.24%238.04M
-40.16%277.22M
-4.88%313.67M
-7.91%354.21M
-6.65%412.14M
-5.96%463.23M
-39.05%329.77M
-4.55%384.63M
-3.79%441.50M
0.59%492.57M
47.31%541.09M
3.94%402.97M
9.88%458.88M
7.69%489.69M
-24.37%367.31M
-20.79%387.70M
-13.00%417.62M
-9.69%454.72M
100.82%485.66M
83.64%489.44M
Cash Flow Statement
Net operating income
18.63%-45.39M
25.78%-34.84M
3.23%-50.42M
9.03%-48.96M
1.87%-55.79M
-60.00%-46.94M
8.83%-52.10M
-5.81%-53.82M
1.22%-56.86M
47.63%-29.34M
-30.30%-57.15M
-30.30%-50.87M
-46.75%-57.56M
-81.06%-56.02M
-59.99%-43.86M
-1.33%-39.04M
-61.52%-39.22M
-136.03%-30.94M
-58.89%-27.41M
-74.86%-38.53M
Net investment
130.06%17.45M
196.18%36.42M
18.62%93.62M
-42.90%31.76M
-265.65%-58.03M
73.10%-37.87M
63.55%78.92M
78.25%55.62M
195.41%35.03M
-29.67%-140.81M
105.64%48.25M
-60.39%31.21M
41.71%-36.72M
-743.89%-108.58M
229.01%23.46M
59.65%78.79M
-115.93%-62.99M
130.96%16.86M
71.67%-18.19M
1008.04%49.35M
Net financing
---1.00K
-100.00%0.00
-138.07%-67.00K
-85.95%215.00K
-100.00%0.00
46664.45%182.85M
-99.91%176.00K
740.66%1.53M
-93.55%1.18M
-99.64%391.00K
541.76%189.49M
-98.94%182.00K
24035.53%18.34M
9445.77%108.44M
10.84%29.53M
1446.73%17.25M
-99.14%76.00K
-99.60%1.14M
5102.73%26.64M
638.41%1.11M

FAQs

What are the current assets of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its current assets were 192.73M, with a year-on-year change of -49.04.

What are the total assets of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its total assets of Rocket Pharmaceuticals Inc were 330.45M, with a year-on-year change of -37.38.

What are the total liabilities of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Rocket Pharmaceuticals Inc were 53.23M, with a year-on-year change of -17.43.

What is the total equity of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its total equity of Rocket Pharmaceuticals Inc was 277.22M, with a year-on-year change of -40.16.

What is the net operating income of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Rocket Pharmaceuticals Inc was -228.52M, with a year-on-year change of 16.36.

What is the net investment of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its net investment of Rocket Pharmaceuticals Inc was 103.77M, with a year-on-year change of -21.21.

What is the net financing of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its net financing of Rocket Pharmaceuticals Inc was 148.00K, with a year-on-year change of -99.92.

What is the Earnings Per Share (EPS) of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.01, with a year-on-year change of 26.43.

What is the net income of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its net income was -223.12M, with a year-on-year change of 13.77.

What is the debt-to-asset ratio of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 6.44, with a year-on-year change of 59.96.

What is the Return on Equity (ROE) of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -60.27, with a year-on-year change of -11.31.

What is the Return on Assets (ROA) of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -52.00, with a year-on-year change of -9.94.

What is the operating profit of Rocket Pharmaceuticals Inc?

According to Rocket Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -228.52M, with a year-on-year change of 16.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy